LINK Healthcare has confirmed
that there will be no further
supplly of Deseril (methysergide as
maleate) 1mg tablets.
The move comes despite vigorous
efforts working with the current
manufacturer, Amdipharm Mercury
Company limited (AMCo) “to
establish a sustainable supply of
this important medicinal product.”
Deseril is an ergot alkaloid
which is used in the prevention
of migraine headaches as well as
other indications including the
treatment of diarrhoea linked to
carcinoid syndrome.
Link Healthcare says it has no
alternative but to cease supply
of the product, with attempts to
source an alternative supply from
the global market also a failure.
“All practitioners should consider
alternative treatments for their
patients who are currently taking
methysergide,” the company said.
More info on 1800 181 060.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Oct 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Oct 13
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.